What podcasts say about The Estée Lauder Companies Inc.
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about The Estée Lauder Companies Inc.
16 statements · 15 positive · 1 negative
Investors prefer Estée Lauder remaining independent rather than merging with a Spanish brand.
“investors are a lot happier that they decided to stay as a standalone”
Open the episode · Weekly Roundup: Moderna Skyrockets, Crowdstrike Sinks, Estée Lauder JumpsListen at 4:01
Estée Lauder fourth-quarter net sales exceeded $3.6 billion after rising over 6%.
“Net sales climbed more than 6% to $3.6 billion in the fiscal fourth quarter.”
Open the episode · Moderna's Record Surge, Estee Lauder Rises on Q4 Beat, La-Z-Boy SinksListen at 2:09
Estée Lauder’s turnaround is gaining momentum.
“Their turnaround is picking up steam.”
Open the episode · Moderna's Record Surge, Estee Lauder Rises on Q4 Beat, La-Z-Boy SinksListen at 2:14
Estée Lauder stock rose 12.5%.
“stock is up 12 and a half percent”
Open the episode · Moderna's Record Surge, Estee Lauder Rises on Q4 Beat, La-Z-Boy SinksListen at 2:14
Estée Lauder shares rose 16%, their best day since November 2011.
“Estee Lauder shares up 16%. Carol, best day since November of 2011.”
Open the episode · Closing Bell: Moderna Surges, Estee Lauder Soars, TJ Maxx DeclinesListen at 2:17
Estée Lauder reported $3.6 billion revenue and 5% organic sales growth.
“Company reported revenue of $3.6 billion in its fiscal fourth quarter, and organic sales growth accelerated to 5%”
Open the episode · Closing Bell: Moderna Surges, Estee Lauder Soars, TJ Maxx DeclinesListen at 2:21
Estée Lauder lost less money than analysts expected.
“They lost less money than expected last quarter”
Open the episode · Moderna's Record Surge, Estee Lauder Rises on Q4 Beat, La-Z-Boy SinksListen at 2:29
Estée Lauder reported $3.6 billion revenue and 5% organic sales growth in its fiscal fourth quarter.
“Company reported revenue of 3.6 billion in its fiscal fourth quarter and organic sales growth accelerated to 5%”
Open the episode · Closing Bell: Moderna Surges, Estee Lauder Soars, TJ Maxx DeclinesListen at 2:36
Estée Lauder’s turnaround is gaining momentum.
“Their turnaround is picking up. Steam”
Open the episode · Moderna's Record Surge, Estee Lauder Rises on Q4 Beat, La-Z-Boy SinksListen at 2:36
Estée Lauder’s stock remained about 74% below its January 2022 high.
“the stock is down, or at least it was down about 74% from a high back in early January of 2022”
Open the episode · Closing Bell: Moderna Surges, Estee Lauder Soars, TJ Maxx DeclinesListen at 2:48
Estée Lauder guides for 3–5% organic net sales growth in the coming year.
“They're continuing to guide for organic net sales growth of 3 to 5% in the coming year”
Open the episode · Moderna's Record Surge, Estee Lauder Rises on Q4 Beat, La-Z-Boy SinksListen at 2:53
Estée Lauder’s Asia-Pacific growth reached 5%, exceeding Wall Street expectations.
“a lot of that growth was driven out of Asia-Pacific. 5% growth by that measure, and that's stronger than Wall Street had anticipated.”
Open the episode · Target Posts Comp Sales Beat, Lowe's Slips on Outlook, Moderna Soars on Melanoma StudyListen at 3:58
Estée Lauder stock gained 16%, its largest increase in nearly 15 years.
“a 16% gain. That's the biggest gain in almost 15 years.”
Open the episode · Moderna Soars, SK Hynix Jumps, Estee Lauder GainsListen at 4:06
Estée Lauder reported fourth-quarter revenue above estimates and 5% organic sales growth.
“good set of results. Fourth quarter revenue beating estimates organic sales of 5%.”
Open the episode · Moderna Soars, SK Hynix Jumps, Estee Lauder GainsListen at 4:11
Estée Lauder’s restructuring appears pivotal to its turnaround.
“it seems pivotal for the company. Right. It's been trying to turn itself around for a couple of years now.”
Open the episode · Moderna Soars, SK Hynix Jumps, Estee Lauder GainsListen at 4:28
Estée Lauder projects fiscal-2027 EPS above Wall Street expectations.
“Estee Lauder also projecting fiscal year 2027 EPS that point towards a bottom line that will be higher than Wall street was expecting.”
Open the episode · Target Posts Comp Sales Beat, Lowe's Slips on Outlook, Moderna Soars on Melanoma StudyListen at 4:30
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.